Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Chlorpheniramine Maleate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II/ Phase III
Sponsor : Hospital CEMESA Cortés, San Pedro Sula, Honduras
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Chlorpheniramine Maleate is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of COVID-19.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 02, 2023
Lead Product(s) : Chlorpheniramine Maleate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II/ Phase III
Sponsor : Hospital CEMESA Cortés, San Pedro Sula, Honduras
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Chlorpheniramine Maleate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II/ Phase III
Sponsor : Hospital CEMESA Cortés, San Pedro Sula, Honduras
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Chlorpheniramine Maleate is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of COVID-19.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 08, 2022
Lead Product(s) : Chlorpheniramine Maleate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II/ Phase III
Sponsor : Hospital CEMESA Cortés, San Pedro Sula, Honduras
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Chlorpheniramine Maleate
Therapeutic Area : Undisclosed
Study Phase : Phase III
Sponsor : Techtrials Pesquisa e Tecnologia Ltda | Pharmagenix
Deal Size : Inapplicable
Deal Type : Inapplicable
Study Comparing Coristina® D to Resfenol® in the Symptomatic Treatment of Common Cold
Details : Chlorpheniramine Maleate is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 12, 2016
Lead Product(s) : Chlorpheniramine Maleate
Therapeutic Area : Undisclosed
Highest Development Status : Phase III
Sponsor : Techtrials Pesquisa e Tecnologia Ltda | Pharmagenix
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Chlorpheniramine Maleate
Therapeutic Area : Immunology
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Exploratory Study for Allergy Relief Onset
Details : Chlorpheniramine Maleate is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Rhinitis, Allergic.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 29, 2016
Lead Product(s) : Chlorpheniramine Maleate
Therapeutic Area : Immunology
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable